MABXIENCE Trademark

Trademark Overview


On Thursday, July 28, 2016, a trademark application was filed for MABXIENCE with the United States Patent and Trademark Office. The USPTO has given the MABXIENCE trademark a serial number of 79975374. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, December 6, 2024. This trademark is owned by MABXIENCE RESEARCH, S.L.. The MABXIENCE trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for the treatment of ophthalmic diseases and disorders, dermatological diseases and disorders, pharmaceutical preparations for use in treating digestive diseases and disorders, gynecological diseases and disorders, hormonal diseases and disorders, blood disorders, cancer, cardiovascular diseases, vascular diseases, gastrointestinal diseases, genitourinary diseases, genitourinary disorders, immunologic diseases, infectious diseases, inflammatory diseases, metabolic diseases and disorders, neurological diseases, psychiatric diseases, central nervous system; pharmaceutical preparations for the treatment of diseases of the musculoskeletal system, diseases of the respiratory system, circulatory system, circulatory diseases, viral diseases, glaucoma, dental and oral diseases, headaches, migraine, obesity, hepatic treatments, treatment of the liver, cholesterol, blood pressure and rheumatic treatments; veterinary preparations for treating digestive diseases and dis...

Chemical, biological and pharmaceutical research services
mabxience

General Information


Serial Number79975374
Word MarkMABXIENCE
Filing DateThursday, July 28, 2016
Status709 - CANCELLED - SECTION 71
Status DateFriday, December 6, 2024
Registration Number5472348
Registration DateTuesday, May 22, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 6, 2018

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of ophthalmic diseases and disorders, dermatological diseases and disorders, pharmaceutical preparations for use in treating digestive diseases and disorders, gynecological diseases and disorders, hormonal diseases and disorders, blood disorders, cancer, cardiovascular diseases, vascular diseases, gastrointestinal diseases, genitourinary diseases, genitourinary disorders, immunologic diseases, infectious diseases, inflammatory diseases, metabolic diseases and disorders, neurological diseases, psychiatric diseases, central nervous system; pharmaceutical preparations for the treatment of diseases of the musculoskeletal system, diseases of the respiratory system, circulatory system, circulatory diseases, viral diseases, glaucoma, dental and oral diseases, headaches, migraine, obesity, hepatic treatments, treatment of the liver, cholesterol, blood pressure and rheumatic treatments; veterinary preparations for treating digestive diseases and disorders, gynecological diseases and disorders, blood disorders, cancer, cardiovascular diseases, vascular diseases, gastrointestinal diseases, genitourinary diseases, immunologic diseases, infectious diseases, inflammatory diseases, metabolic diseases and disorders, neurological diseases, central nervous system, musculoskeletal system, respiratory system, circulatory system, viral diseases, glaucoma, dental and oral diseases, headaches, migraine, obesity, hepatic treatments, cholesterol, blood pressure and rheumatic treatments, and dietetic foods adapted for medical use, namely, breads, pastas, crackers, chips, packaged meals, nutritional food bars, candy, dips, sauces and food supplements in pill, powder capsule, beverage form, effervescent tablet and liquid form
Goods and ServicesChemical, biological and pharmaceutical research services

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, December 6, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, December 6, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMABXIENCE RESEARCH, S.L.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressE-28050 MADRID (MADRID)
ES

Party NameMABXIENCE RESEARCH, S.L.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressE-28050 MADRID (MADRID)
ES

Party NameMABXIENCE RESEARCH, S.L.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressE-28050 MADRID (MADRID)
ES

Trademark Events


Event DateEvent Description
Thursday, November 24, 2016SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Thursday, December 1, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 1, 2016ASSIGNED TO EXAMINER
Friday, December 2, 2016NON-FINAL ACTION WRITTEN
Saturday, December 3, 2016NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, December 5, 2016REFUSAL PROCESSED BY MPU
Monday, December 5, 2016NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, December 6, 2016APPLICATION FILING RECEIPT MAILED
Friday, December 30, 2016REFUSAL PROCESSED BY IB
Thursday, January 5, 2017CHANGE OF OWNER RECEIVED FROM IB
Monday, June 5, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, June 5, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, June 5, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 5, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 6, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 27, 2017NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, June 27, 2017FINAL REFUSAL E-MAILED
Tuesday, June 27, 2017FINAL REFUSAL WRITTEN
Wednesday, December 27, 2017TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, December 27, 2017DIVISIONAL REQUEST RECEIVED
Wednesday, December 27, 2017TEAS REQUEST TO DIVIDE RECEIVED
Thursday, December 28, 2017EXPARTE APPEAL RECEIVED AT TTAB
Thursday, December 28, 2017EX PARTE APPEAL-INSTITUTED
Thursday, December 28, 2017JURISDICTION RESTORED TO EXAMINING ATTORNEY
Thursday, January 11, 2018ASSIGNED TO LIE
Tuesday, January 16, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, January 19, 2018DIVISIONAL PROCESSING COMPLETE
Tuesday, January 23, 2018NOTICE OF DIVIDED TRADEMARK APPLICATION MAILED
Tuesday, January 30, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 14, 2018NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, February 14, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 14, 2018NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, March 6, 2018PUBLISHED FOR OPPOSITION
Tuesday, March 6, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, March 9, 2018NOTIFICATION PROCESSED BY IB
Friday, March 16, 2018NOTIFICATION PROCESSED BY IB
Wednesday, April 25, 2018NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, April 25, 2018NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Friday, May 11, 2018NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Tuesday, May 22, 2018REGISTERED-PRINCIPAL REGISTER
Wednesday, August 22, 2018FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, August 30, 2018FINAL DISPOSITION PROCESSED
Thursday, August 30, 2018FINAL DISPOSITION NOTICE SENT TO IB
Friday, September 21, 2018FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, September 26, 2022INTERNATIONAL REGISTRATION RENEWED
Friday, December 6, 2024CANCELLED SECTION 71